Pharmacological mechanism of roflumilast in the treatment of asthma–COPD overlap

MLA

Zhang X, et al. “Pharmacological Mechanism of Roflumilast in the Treatment of Asthma–COPD Overlap.” Drug Design, Development and Therapy, vol. ume 12, Aug. 2018, pp. 2371–79. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsdoj&AN=edsdoj.fe0d47fda0aa479c987bf9c7e2e31653&authtype=sso&custid=ns315887.

APA

Zhang X, Chen Y, Fan L, Ye J, Fan J, Xu X, You D, Liu S, Chen X, & Luo P. (2018). Pharmacological mechanism of roflumilast in the treatment of asthma–COPD overlap. Drug Design, Development and Therapy, ume 12, 2371–2379.

Chicago

Zhang X, Chen Y, Fan L, Ye J, Fan J, Xu X, You D, Liu S, Chen X, and Luo P. 2018. “Pharmacological Mechanism of Roflumilast in the Treatment of Asthma–COPD Overlap.” Drug Design, Development and Therapy ume 12 (August): 2371–79. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsdoj&AN=edsdoj.fe0d47fda0aa479c987bf9c7e2e31653&authtype=sso&custid=ns315887.